Cock Bombs 70 mg is an oral combination tablet manufactured by Dragon Pharma, containing 50 mg of sildenafil citrate and 20 mg of tadalafil citrate per tablet in a 100-tablet package.
Cock Bombs 70 mg combines two phosphodiesterase type 5 (PDE5) inhibitors—sildenafil citrate and tadalafil citrate—into a single oral tablet. Both compounds work by inhibiting the PDE5 enzyme, which is responsible for degrading cyclic guanosine monophosphate (cGMP). When sexual stimulation causes the local release of nitric oxide, inhibition of PDE5 produces increased levels of cGMP in the corpus cavernosum, resulting in smooth muscle relaxation and increased blood flow . Sildenafil is the active ingredient in Viagra, while tadalafil is the active ingredient in Cialis .
In medical practice, sildenafil and tadalafil are each approved individually for the treatment of erectile dysfunction, with tadalafil also approved for benign prostatic hyperplasia . The combination of two PDE5 inhibitors in a single product is not an FDA-approved formulation, and no clinical trials have established the safety or efficacy of this combination. In non-medical bodybuilding contexts, combination PDE5 products are sometimes referenced for their vasodilatory and blood flow effects, though such use falls outside approved medical indications.
The pharmacokinetic profiles of the two compounds differ significantly. Sildenafil has a terminal half-life of approximately 3 to 5 hours and reaches peak plasma concentrations within 30 to 120 minutes . Tadalafil has a much longer half-life of approximately 17.5 hours and reaches peak plasma concentrations between 30 minutes and 6 hours . This difference in half-life means the two compounds have different durations of action, which is relevant to how the combination product behaves in the body. The 50 mg sildenafil and 20 mg tadalafil doses in Cock Bombs align with the maximum recommended on-demand doses for each compound individually .
Cock Bombs 70 mg is supplied as an oral tablet containing 50 mg of sildenafil citrate and 20 mg of tadalafil citrate per tablet. Oral administration allows for convenient dosing without the need for injection equipment.
Sildenafil and tadalafil are both selective PDE5 inhibitors that work through the same mechanism but have different pharmacokinetic profiles, with sildenafil being shorter-acting and tadalafil being longer-acting.
Sildenafil citrate is a selective inhibitor of cGMP-specific PDE5. Its chemical formula is C22H30N6O4S, with a molecular weight of 666.7 g/mol . Sildenafil is rapidly absorbed after oral administration, with absolute bioavailability of approximately 41%. Maximum observed plasma concentrations are reached within 30 to 120 minutes of oral dosing in the fasted state, and the terminal half-life is approximately 4 hours . Sildenafil is predominantly metabolized by CYP3A4 and CYP2C9, and it is excreted as metabolites predominantly in the feces and to a lesser extent in the urine .
Tadalafil citrate is also a selective, reversible inhibitor of cGMP-specific PDE5. Its chemical formula is C22H19N3O4, with a molecular weight of 389.4 g/mol . After single oral-dose administration, the mean terminal half-life is 17.5 hours in healthy subjects . Tadalafil exposure (AUC) increases proportionally with dose over a range of 2.5 to 20 mg. Steady-state plasma concentrations are attained within 5 days of once-daily dosing . Tadalafil is predominantly metabolized by CYP3A4 and excreted mainly in the feces and to a lesser extent in the urine .
The two compounds share the same mechanism of action—PDE5 inhibition—but their different half-lives mean they contribute differently to the overall effect of the combination. Sildenafil provides a faster onset and shorter duration, while tadalafil provides a slower onset but extended duration. Combining them in a single tablet is not an FDA-approved formulation, and the safety and efficacy of this combination have not been established in clinical trials.
Sildenafil has a terminal half-life of approximately 4 hours, while tadalafil has a terminal half-life of approximately 17.5 hours . This difference means the combination provides both rapid onset and extended duration, but also raises questions about cumulative PDE5 inhibition that have not been studied clinically.
Dragon Pharma offers a range of compounds relevant to men's health and performance. Cock Bombs 70 mg is positioned as a combination PDE5 inhibitor product, complementing the individual compounds also available.
For single-agent sildenafil, Dragon Pharma offers Viagra, which contains 100 mg of sildenafil per tablet. For single-agent tadalafil, Dragon Pharma offers Cialis, which contains 20 mg of tadalafil per tablet. For an alternative PDE5 inhibitor with a different duration profile, Levitra is also available.
The information below is provided for educational reference only. Sildenafil and tadalafil are prescription medications; medical use requires appropriate diagnosis, clinical supervision and ongoing monitoring. Non-medical use falls outside approved indications, and the combination of two PDE5 inhibitors in one product is not FDA-approved.
In medical practice, sildenafil is dosed at 50 mg as needed for erectile dysfunction, with a maximum of one dose per day . Tadalafil is dosed at 10 mg as needed, with the dose potentially increased to 20 mg or decreased to 5 mg, and a maximum of one dose per day . There is no approved medical dosing for the combination of both compounds in a single tablet. In non-medical contexts, combination PDE5 products are sometimes referenced, but no established dosing range exists for this specific combination, and the cumulative PDE5 inhibition from taking both compounds together has not been characterized.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Medical (sildenafil alone, ED) | 50 mg | As needed, max once daily |
| Medical (tadalafil alone, ED) | 10–20 mg | As needed, max once daily |
| Combination product (non-medical) | Not established | Not established |
No clinical trials have established the safety or efficacy of combining sildenafil and tadalafil in a single dose. The 70 mg tablet contains the maximum on-demand dose of each compound individually.
Cock Bombs 70 mg contains two active compounds and should not be stacked with additional PDE5 inhibitors. The combination of sildenafil and tadalafil already provides dual PDE5 inhibition; adding a third PDE5 inhibitor would increase the risk of adverse effects without established benefit.
For single-agent alternatives, Dragon Pharma offers Viagra (sildenafil) and Cialis (tadalafil), which allow for simpler dose titration. For a different PDE5 inhibitor with a different duration profile, Levitra is also available.
The side effect profile of the combination would be expected to reflect the additive effects of both compounds. Sildenafil's most common adverse reactions include headache, flushing, dyspepsia, nasal congestion, and visual disturbances . Tadalafil's most common adverse reactions include headache, dyspepsia, back pain, myalgia, nasal congestion, and flushing . Both compounds can potentiate the hypotensive effects of nitrates, and the combination of either with nitrates is absolutely contraindicated .
Because both compounds inhibit the same enzyme, the combination may produce more pronounced PDE5 inhibition than either alone. This could theoretically amplify both therapeutic effects and adverse effects, including hypotension, headache, and nasal congestion. No clinical data exists to quantify this risk.
Cock Bombs 70 mg is not part of standard post-cycle therapy protocols, which focus on restoring endogenous testosterone production. PCT compounds such as Clomid and Nolvadex address the hypothalamic-pituitary-gonadal axis rather than PDE5 inhibition. The role of PDE5 inhibitors is generally limited to on-demand or daily use for erectile function and blood flow.
Dosing strategies and support protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice. The combination of two PDE5 inhibitors in a single product is not FDA-approved.
Sildenafil and tadalafil are prescription PDE5 inhibitors that can affect cardiovascular function. The combination of both compounds in a single product is not FDA-approved and has not been evaluated in clinical trials.
Both sildenafil and tadalafil are contraindicated in patients taking any form of nitrates, either regularly or intermittently. Both compounds have been shown to potentiate the hypotensive effect of nitrates . Administration with guanylate cyclase stimulators such as riociguat is also contraindicated for both compounds . The combination of two PDE5 inhibitors is not FDA-approved, and no clinical trials have established the safety of this combination.
Non-medical use of combination PDE5 inhibitors for blood flow or performance enhancement is not approved by regulatory agencies and may carry additional health risks. Product quality does not establish that non-medical use is safe or appropriate.
Sildenafil's most common adverse reactions (≥2%) include headache, flushing, dyspepsia, nasal congestion, and visual disturbances (including color tinge, increased sensitivity to light, blurred vision) . Tadalafil's most common adverse reactions (≥2%) include headache, dyspepsia, back pain, myalgia, nasal congestion, flushing, and pain in limb .
Both compounds can potentiate the hypotensive effects of nitrates, alpha-blockers, antihypertensives, or alcohol . Use of either compound with alpha-blockers, antihypertensives, or substantial amounts of alcohol may lead to hypotension . Patients should seek emergency treatment if an erection lasts more than 4 hours .
Because both compounds inhibit the same enzyme (PDE5), the combination may produce more pronounced PDE5 inhibition than either alone. This could theoretically amplify both therapeutic effects and adverse effects, including hypotension, headache, and nasal congestion. No clinical data exists to quantify this risk.
Both sildenafil and tadalafil are not recommended in patients with a history of certain cardiovascular conditions, including myocardial infarction within the last 90 days, unstable angina or angina occurring during sexual intercourse, New York Heart Association Class 2 or greater heart failure in the last 6 months, uncontrolled arrhythmias, hypotension (less than 90/50 mm Hg), uncontrolled hypertension, or stroke within the last 6 months . Before initiating PDE5 inhibitor therapy for BPH, consideration should be given to other urological conditions that may cause similar symptoms .
Medically supervised PDE5 inhibitor therapy typically involves assessment of treatment response and monitoring for adverse effects. In patients taking alpha-blockers, caution is advised and blood pressure should be monitored . For patients with hepatic impairment or renal impairment, dose adjustments may be necessary for both compounds individually, but no guidance exists for the combination product .
Keep the product securely stored and protected from conditions that could compromise the tablets or packaging. Inspect the product before use and do not use if it appears damaged or otherwise abnormal. Keep all medications out of the reach of children.
Cock Bombs 70 mg is supplied through the official Dragon Pharma distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official Dragon Pharma distribution chain.
To verify your Cock Bombs 70 mg product, use the security code on the packaging and cross-check it on the Dragon Pharma official site. Official Dragon Pharma presentation and original packaging help reinforce product legitimacy and buyer confidence.
Proper storage conditions help preserve tablet integrity and stability throughout shelf life.
Store in a cool, dry place at controlled room temperature (15–25°C). Protect from excessive heat, moisture, and direct light. Keep the tablets in their original packaging until use.
Do not use if the packaging appears damaged or if the tablets show signs of deterioration. Keep out of reach of children.
Answers to common questions about Cock Bombs 70 mg, the sildenafil and tadalafil combination, product strength and safety considerations.
Cock Bombs 70 mg contains sildenafil citrate and tadalafil citrate, both PDE5 inhibitors. In medical practice, sildenafil and tadalafil are each used individually for erectile dysfunction, with tadalafil also approved for benign prostatic hyperplasia. The combination of both compounds in a single product is not FDA-approved. In non-medical bodybuilding contexts, combination PDE5 products are sometimes referenced for blood flow, though such use falls outside approved medical indications.
No established dosing range exists for the combination of sildenafil and tadalafil in a single product. In medical practice, sildenafil 50 mg is taken as needed, with a maximum of one dose per day, and tadalafil 10–20 mg is taken as needed, also with a maximum of one dose per day . Taking both compounds together has not been evaluated in clinical trials.
Cock Bombs 70 mg is not part of standard post-cycle therapy, which focuses on restoring endogenous testosterone production. PCT compounds like Clomid and Nolvadex address the hypothalamic-pituitary-gonadal axis rather than PDE5 inhibition. The role of PDE5 inhibitors is generally limited to on-demand or daily use for erectile function and blood flow.
Sildenafil and tadalafil are both selective PDE5 inhibitors. They work by inhibiting the PDE5 enzyme, which is responsible for degrading cGMP. When sexual stimulation causes the local release of nitric oxide, inhibition of PDE5 produces increased levels of cGMP in the corpus cavernosum, resulting in smooth muscle relaxation and increased blood flow . Both compounds work through the same mechanism but have different pharmacokinetic profiles.
The onset and duration of Cock Bombs 70 mg would reflect the combined pharmacokinetics of both compounds. Sildenafil reaches peak plasma concentrations within 30 to 120 minutes and has a terminal half-life of approximately 4 hours . Tadalafil reaches peak plasma concentrations between 30 minutes and 6 hours and has a terminal half-life of approximately 17.5 hours . The combination has not been studied clinically.
No combination of PDE5 inhibitors is approved for medical use, and no clinical trials have established the safety or efficacy of combining sildenafil and tadalafil. Individual PDE5 inhibitors such as Viagra and Cialis are each approved for erectile dysfunction and have established safety profiles. The appropriate choice depends on individual response and circumstances.
Cock Bombs 70 mg contains both sildenafil and tadalafil, while Viagra contains only sildenafil. Sildenafil alone has a shorter half-life of approximately 4 hours, while the tadalafil in Cock Bombs has a half-life of approximately 17.5 hours . The combination product has not been clinically evaluated, whereas sildenafil alone has an established safety and efficacy profile.
Cock Bombs 70 mg contains both sildenafil and tadalafil, while Cialis contains only tadalafil. Tadalafil alone has a longer half-life of approximately 17.5 hours, while the sildenafil in Cock Bombs has a shorter half-life of approximately 4 hours . The combination product has not been clinically evaluated, whereas tadalafil alone has an established safety and efficacy profile.
The 70 mg total strength of Cock Bombs reflects 50 mg sildenafil plus 20 mg tadalafil. The 50 mg sildenafil dose is the standard starting dose for erectile dysfunction, and the 20 mg tadalafil dose is the maximum recommended on-demand dose . However, no clinical data exists on the safety of taking both compounds together at these doses. The combination has not been studied in clinical trials.
Cock Bombs 70 mg is labeled at 50 mg of sildenafil citrate and 20 mg of tadalafil citrate per tablet, for a total of 70 mg per tablet. It is supplied in a 100-tablet package, giving 7,000 mg of total labeled active content.
Both sildenafil and tadalafil can potentiate the hypotensive effects of nitrates, alpha-blockers, antihypertensives, or alcohol . The combination of either compound with nitrates is absolutely contraindicated due to the risk of severe, potentially life-threatening hypotension . Because Cock Bombs contains both compounds, the potential for hypotensive effects may be additive, though this has not been studied clinically. Caution is advised, particularly in individuals taking blood pressure medications.
No. The combination of sildenafil and tadalafil in a single tablet is not FDA-approved. Sildenafil and tadalafil are each individually approved for the treatment of erectile dysfunction, and tadalafil is also approved for benign prostatic hyperplasia . However, no regulatory agency has approved the combination of these two compounds in a single product, and the safety and efficacy of this combination have not been established.